The study of clinical bioequivalence drug Nativa (generic desmopressin acetate tablets) in patients with central diabetes insipidus
https://doi.org/10.14341/omet2016146-48
Abstract
Materials and methods. The study included 15 patients (9 women and 6 men) with central diabetes insipidus (CDI), compensated by therapy with a tablet formulation Minirin (diuresis up to 3000 ml). The average age of the patients was 44 ± 8 years. For 3 days during treatment Minirin we evaluated the clinical manifestations of the CDI. On the fourth day, Minirin was replaced by Nativa in the equivalent dose, with further correction whennecessary. From the 4th to the 6th day of treatment with Nativawe assessed the same parameters as on the initial therapy.
Results. The vast majority of patients did not require dose adjustment and, if necessary, dose adjustment was small and accounted for about 20% of the original dose. Average dose did not differ in patients receiving Minirin or Nativa, 0.43 ± 0.26 vs. 0.45 ± 0.32 (p> 0.05).
Conclusions. Nativa is characterized by therapeutic equivalence to Minirin in patients with a central form of diabetes insipidus.
About the Authors
Ekaterina A. Pigarova
Endocrinology Research Centre
Russian Federation
Russian Federation
Larisa K. Dzeranova
Endocrinology Research Centre
Russian Federation
Russian Federation
References
1. Пигарова Е.А., Дзеранова Л.К. Диагностика и лечение центрального несахарного диабета // Ожирение и метаболизм. – 2014. – Т. 11. – №. 4. – С. 48-55. [Pigarova EA, Dzeranova LK. Diagnosis and treatment of central diabetes insipidus. Obesity and metabolism. 2014;11(4):48-55. (In Russ.)] doi: 10.14341/omet2014448-55
2. Ebell MH, Radke T, Gardner J. A Systematic Review of the Efficacy and Safety of Desmopressin for Nocturia in Adults. The Journal of Urology. 2014;192(3):829-35. doi:10.1016/j.juro.2014.03.095
3. Пигарова Е.А., Дзеранова Л.К., Рожинская Л.Я. Индивидуализация терапии центрального несахарного диабета: клинический случай применения препарата «Пресайнекс» //Ожирение и метаболизм. – 2010. – №. 3. [Pigarova EA, Dzeranova LK, Rozhinskaya LY. Individualizatsiya terapii tsentral'nogo nesakharnogo diabeta: klinicheskiy sluchay primeneniya preparata «Presayneks». Obesity and metabolism. 2010;7(3):39-41. (In Russ.)] doi: 10.14341/2071-8713-4983
4. Дедов И.И., Пигарова Е.А., Рожинская Л.Я. Открытое проспективное клиническое исследование по оценке эффективности и безопасности применения десмопрессина в форме назального спрея у пациентов с центральным несахарным диабетом: фармакоэкономические аспекты // Лечащий врач. – 2010. – Т. 9. – С. 2-5. [Dedov II, Pigarova EA, Rozhinskaya LYa. Otkrytoe prospektivnoe klinicheskoe issledovanie po otsenke effektivnosti i bezopasnosti primeneniya desmopressina v forme nazal'nogo spreya u patsientov s tsentral'nym nesakharnym diabetom. Lechashchiy vrach. 2010; 9:108. (In Russ.)]
5. Пигарова Е.А., Дзеранова Л.К., Рожинская Л.Я. Клинический случай применения пресайнекса у пациента с центральным несахарным диабетом вследствие гистиоцитоза Лангерганса //Эффективная фармакотерапия. – 2011. – №. 46. – С. 60-65. [Pigarova EA, Dzeranova LK, Rozhinskaya LYa. Klinicheskiy sluchay primeneniya Presayneksa u patsienta s tsentral'nym nesakharnym diabetom vsledstvie gistiotsitoza Langergansa. Effektivnaya farmakoterapiya. 2011;(46):60-65. (In Russ.)]
6. Соколов А., Кукес В., Бунятян Н., и соавт. Терапевтическая эквивалентность, биоэквивалентность и взаимозаменяемость лекарственных средств. // Врач. – 2015. – № 10. – С. 32-35.[ Sokolov A, Kukes V, Bunyatyan N et al. Terapevticheskaya ekvivalentnost', bioekvivalentnost' i vzaimozamenyaemost' lekarstvennykh sredstv. Vrach. 2015;(10):32-35. (In Russ.)]
7. Толпыгина С.Н. Дженерическая замена: проблема выбора //Кардиоваскулярная терапия и профилактика. – 2009. – Т. 8. – №. 3. – С. 87-93. [Tolpygina SN. Dzhenericheskaya zamena: problema vybora. Kardiovaskulyarnaya terapiya i profilaktika. 2009; 8(3): 87-93. (In Russ.)]
Review
For citations:
Pigarova E.A., Dzeranova L.K. The study of clinical bioequivalence drug Nativa (generic desmopressin acetate tablets) in patients with central diabetes insipidus. Obesity and metabolism. 2016;13(1):46-48. (In Russ.) https://doi.org/10.14341/omet2016146-48
Views:
644
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
